| 000 | 01396 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514080711.0 | ||
| 264 | 0 | _c20040505 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1079-9796 | ||
| 024 | 7 |
_a10.1016/s1079-9796(03)00156-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeBellis, Robert H | |
| 245 | 0 | 0 |
_aInhibition of sickling in vitro by three purine-based antiviral agents: an approach to the treatment of sickle cell disease. _h[electronic resource] |
| 260 |
_bBlood cells, molecules & diseases _c |
||
| 300 |
_a286-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcyclovir _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnemia, Sickle Cell _xdrug therapy |
| 650 | 0 | 4 |
_aAntiviral Agents _xchemistry |
| 650 | 0 | 4 | _aCell Aggregation |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 |
_aGanciclovir _xchemistry |
| 650 | 0 | 4 |
_aHemoglobin, Sickle _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOxygen _xmetabolism |
| 650 | 0 | 4 | _aValacyclovir |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 700 | 1 | _aChen, Bi-Xing | |
| 700 | 1 | _aErlanger, Bernard F | |
| 773 | 0 |
_tBlood cells, molecules & diseases _gvol. 31 _gno. 2 _gp. 286-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1079-9796(03)00156-6 _zAvailable from publisher's website |
| 999 |
_c12739333 _d12739333 |
||